ACN Accenture plc - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
ACN Stock | Fundamental Analysis & Investment Insights
NYSE
Technology
Information Technology Services
Current Price
Live
$281.07
Analyst Target
$291.42
+3.7%
Upside
52W High
$398.35
52W Low
$229.4
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
72%
Analysis Accuracy
Accenture's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite solid profitability metrics like a 25.02% ROE and manageable 0.26 Debt/Equity ratio, earnings growth is weakening with a -1.60% YoY decline and bearish insider activity. The stock trades at a significant premium to its Graham Number of $115.99 and intrinsic value of $83.44, currently priced at $281.07, though it remains below the analyst target of $291.42. Mixed signals from strong historical earnings beats (3 out of last 4 quarters) and recent positive EPS growth contrast with deteriorating technical trends and negative insider sentiment.
Key Strengths
Strong return on equity (25.02%) indicating efficient use of shareholder capital
Consistently beats earnings estimates, with 3 out of last 4 quarters showing positive surprises
Low leverage with Debt/Equity ratio of 0.26, suggesting conservative capital structure
Solid operating cash flow generation implied by high operating margin (16.97%)
Attractive dividend yield of 2.29% with sustainable 50.17% payout ratio
Key Risks
Weak Piotroski F-Score of 4/9 signals potential financial instability and operational inefficiencies
Earnings declining YoY (-1.60%) and QoQ (-3.00%), raising concerns about near-term profitability
Bearish technical trend (0/100) and price down 21.9% over the past year
Insider selling activity totaling $2.11M in the last 6 months, signaling lack of confidence
Significant valuation premium: trading at $281.07 vs Graham Number of $115.99 and intrinsic value of $83.44
AI Fair Value Estimate
Based on comprehensive analysis
$115.99
-58.7% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ACN against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning ACN from our newsroom.
Newest → oldest
No matching news yet.